Trials / Completed
CompletedNCT07215260
A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body
The Effect of BI 3000202 on the Pharmacokinetics of Rosuvastatin and Digoxin Given as a Cocktail - an Open-label, Non-randomised, 2-period Fixed-sequence Trial in Healthy Male and Female Trial Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The objective of this trial is to assess the effect of BI 3000202 on the pharmacokinetics of rosuvastatin and digoxin given as a cocktail.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 3000202 | BI 3000202 |
| DRUG | Rosuvastatin | Rosuvastatin |
| DRUG | Digoxin | Digoxin |
Timeline
- Start date
- 2025-11-05
- Primary completion
- 2025-12-07
- Completion
- 2025-12-18
- First posted
- 2025-10-10
- Last updated
- 2025-12-22
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT07215260. Inclusion in this directory is not an endorsement.